Item Number | Policy/Procedure | Date Posted | Comment Period Closed | Status | Document Links | |
---|---|---|---|---|---|---|
2023-UHC-211 | Fecal Calprotectin Testing | 6/15/23 | 7/30/23 | Approved | Fecal Calprotectin Testing | |
2023-LHCC-423 | EPSDT | 6/15/23 | 7/30/23 | Approved | EPSDT | |
2023-UHC-523 | Intrauterine Fetal Surgery | 6/15/23 | 7/30/23 | Approved | Intrauterine Fetal Surgery | |
2023-LHCC-1284 | Preventive Health and Clinical Practice | 6/15/23 | 7/30/23 | Approved | Preventive Health and Clinical Practice | |
2023-UHC-1399 | Glaucoma Surgical Treatment | 6/15/23 | 7/30/23 | Approved | Glaucoma Surgical Treatment | |
2023-UHC-1400 | Occipital Nerve Injections and Ablations | 6/15/23 | 7/30/23 | Approved | Occipital Nerve Injections and Ablations | |
2023-UHC-1852 | Macular Degeneration Treatment Procedures | 6/15/23 | 7/30/23 | Approved | Macular Degeneration Treatment Procedures | |
2023-UHC-1719 | Louisiana BH Supplemental Clinical Care | 6/7/23 | 7/22/23 | Approved | Louisiana BH Supplemental Clinical Care | |
2023-LHCC-635 | Coordination of Benefits (COB)/Third Part Liability/Subrogation (TPL) | 6/7/23 | 7/22/23 | Approved | Coordination of Benefits (COB)/Third Party Liability/Subrogation (TPL) | |
2023-LHCC-982 | Outpatient Applied Behavior Analysis Medical Necessity | 6/7/23 | 7/22/23 | Approved | Outpatient Applied Behavior Analysis Medical Necessity | |
2023-ACLA-1183 | Personal Care Services | 6/7/23 | 7/22/23 | Approved | Personal Care Services | |
2023-UHC-1391 | Intraocular Pressure Measurement | 6/7/23 | 7/22/23 | Approved | Intraocular Pressure Measurement | |
2023-UHC-1401 | Manipulative Therapy | 6/7/23 | 7/22/23 | Approved | Manipulative Therapy | |
2023-Humana-1428 | Preauthorization and Notification List | 6/7/23 | 7/22/23 | Approved | Preauthorization and Notification List | |
2023-UHC-1847 | Spinal Fusion and Decompression | 6/7/23 | 7/22/23 | Approved | Spinal Fusion and Decompression | |
2023-Humana-1929 | HCPCS-Drugs & Biologicals | 6/7/23 | 7/22/23 | Approved | HCPCS-Drugs & Biologicals | |
2023-ACLA-1955 | Blood Pressure Devices | 6/7/23 | 7/22/23 | Approved | Blood Pressure Devices | |
2023-ACLA-1956 | Enteral Nutrition | 6/7/23 | 7/22/23 | Approved | Enteral Nutrition | |
2023-ACLA-1957 | Genetic Testing Breast/Ovarian Cancer | 6/7/23 | 7/22/23 | Approved | Genetic Testing Breast/Ovarian Cancer | |
2023-ACLA-1958 | Wound Care Supplies | 6/7/23 | 7/22/23 | Approved | Wound Care Supplies | |
2023-LHCC-315 | Testing Select GU Conditions | 6/5/23 | 7/20/23 | Approved | Testing Select GU Conditions | |
2023-ACLA-815 | Vitamin D Policy | 6/5/23 | 7/20/23 | Approved | Vitamin D Policy | |
2023-LHCC-1108 | Pediatric Liver Transplant | 6/5/23 | 7/20/23 | Approved | Pediatric Liver Transplant | |
2023-LHCC-1114 | Urodynamic Testing | 6/5/23 | 7/20/23 | Approved | Urodynamic Testing | |
2023-LHCC-1212 | Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation | 6/5/23 | 7/20/23 | Approved | Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation | |
2023-LHCC-1214 | Total Parenteral Nutrition and Intradialytic Parental Nutrition | 6/5/23 | 7/20/23 | Approved | Total Parenteral Nutrition and Intradialytic Parental Nutrition | |
2023-LHCC-1216 | Bariatric Surgery | 6/5/23 | 7/20/23 | Approved | Bariatric Surgery | |
2023-LHCC-1217 | Ultrasound in Pregnancy | 6/5/23 | 7/20/23 | Approved | Ultrasound in Pregnancy | |
2023-LHCC-1227 | Skin and Soft Tissue Substitutes for Chronic Wounds | 6/5/23 | 7/20/23 | Approved | Skin and Soft Tissue Substitutes for Chronic Wounds | |
2023-LHCC-1278 | Evoked Potential Testing | 6/5/23 | 7/20/23 | Approved | Evoked Potential Testing | |
2023-LHCC-1353 | Articular Cartilage Defect Repairs | 6/5/23 | 7/20/23 | Approved | Articular Cartilage Defect Repairs | |
2023-LHCC-1355 | Functional MRI | 6/5/23 | 7/20/23 | Approved | Functional MRI | |
2023-LHCC-1356 | Lung Transplantation | 6/5/23 | 7/20/23 | Approved | Lung Transplantation | |
2023-LHCC-1358 | Pancreas Transplantation | 6/5/23 | 7/20/23 | Approved | Pancreas Transplantation | |
2023-LHCC-1360 | Heart-Lung Transplant | 6/5/23 | 7/20/23 | Approved | Heart-Lung Transplant | |
2023-LHCC-1362 | Nonmyeloablative allogeneric SCT | 6/5/23 | 7/20/23 | Approved | Nonmyeloablative allogeneric SCT | |
2023-LHCC-1363 | Tandem Transplant | 6/5/23 | 7/20/23 | Approved | Tandem Transplant | |
2023-LHCC-1365 | GI Pathogen Nucleic Acid and Detection Panel Testing | 6/5/23 | 7/20/23 | Approved | GI Pathogen Nucleic Acid and Detection Panel Testing | |
2023-LHCC-1378 | Wheelchair Seating | 6/5/23 | 7/20/23 | Approved | Wheelchair Seating | |
2023-LHCC-1379 | Inhaled Nitric Oxide | 6/5/23 | 7/20/23 | Approved | Inhaled Nitric Oxide | |
2023-LHCC-1380 | Multiple Sleep Latency Testing | 6/5/23 | 7/20/23 | Approved | Multiple Sleep Latency Testing | |
2023-LHCC-1381 | Bronchial Thermoplasty | 6/5/23 | 7/20/23 | Approved | Bronchial Thermoplasty | |
2023-LHCC-1385 | Implantable Wireless PAP Monitoring | 6/5/23 | 7/20/23 | Approved | Implantable Wireless PAP Monitoring | |
2023-LHCC-1386 | Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins | 6/5/23 | 7/20/23 | Approved | Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins | |
2023-LHCC-1389 | Endometrial Ablation | 6/5/23 | 7/20/23 | Approved | Endometrial Ablation | |
2023-LHCC-1415 | Pulmonary Function Testing | 6/5/23 | 7/20/23 | Approved | Pulmonary Function Testing | |
2023-UHC-1432 | Pediatric Gait Trainers and Standing Systems | 6/5/23 | 7/20/23 | Approved | Pediatric Gait Trainers and Standing Systems | |
2023-LHCC-1702 | Holter Monitor | 6/5/23 | 7/20/23 | Approved | Holter Monitor | |
2023-LHCC-1741 | AHCT for Sickle Cell Anemia and Thalassemia | 6/5/23 | 7/20/23 | Approved | AHCT for Sickle Cell Anemia and Thalassemia | |
2023-LHCC-1745 | Donor Lymphocyte Infusion | 6/5/23 | 7/20/23 | Approved | Donor Lymphocyte Infusion | |
2023-LHCC-1837 | Obstetrical Home Care Programs | 6/5/23 | 7/20/23 | Approved | Obstetrical Home Care Programs | |
2023-LHCC-1841 | MNC Policy for CPST and PSR | 6/5/23 | 7/20/23 | Approved | MNC Policy for CPST and PSR | |
2023-UHC-1906 | Facility-Based Sleep Studies for OSA | 6/5/23 | 7/20/23 | Approved | Facility-Based Sleep Studies for OSA | |
2023-LHCC-1918 | Diabetes Self-Management Training | 6/5/23 | 7/20/23 | Approved | Diabetes Self-Management Training | |
2023-LHCC-1934 | Experimental Technologies | 6/5/23 | 7/20/23 | Approved | Experimental Technologies | |
2023-LHCC-1935 | Gastric Electrical Stimulation | 6/5/23 | 7/20/23 | Approved | Gastric Electrical Stimulation | |
2023-LHCC-1944 | Laser Therapy for Skin Conditions | 6/5/23 | 7/20/23 | Approved | Laser Therapy for Skin Conditions | |
2023-LHCC-1945 | Homocysteine Testing | 6/5/23 | 7/20/23 | Approved | Homocysteine Testing | |
2023-LHCC-1946 | Low-Frequency US and NNWT | 6/5/23 | 7/20/23 | Approved | Low-Frequency US and NNWT | |
2023-LHCC-1948 | Implantable Loop recorder | 6/5/23 | 7/20/23 | Approved | Implantable Loop recorder | |
2023-ACLA-1951 | Sacral Nerve Modulation Stimulation | 6/5/23 | 7/20/23 | Approved | Sacral Nerve Modulation Stimulation | |
2023-ACLA-1952 | Oral Nutritional Supplements | 6/5/23 | 7/20/23 | Approved | Oral Nutritional Supplements | |
2023-ACLA-1953 | Virtual Colonoscopy | 6/5/23 | 7/20/23 | Approved | Virtual Colonoscopy | |
2023-LDH-7 | MCO Manual > Part 4: Services > In Lieu of Services > Physical Health Services > Outpatient Lactation Support (Proposed effective date = 6/30/2023) | 5/23/2023 | 7/7/2023 | Pending | Outpatient Lactation Support | |
2023-LDH-6 | MCO Manual > Part 4: Services > Pharmacy (Proposed effective date = 8/14/2023) | 5/23/2023 | 7/7/2023 | Pending | Pharmacy | |
2023-LDH-5 | MCO Manual > Part 4: Services > Hospital Services > Outpatient Hospital Services > Common Observation Policy (Effective date = 8/14/2023) | 5/23/2023 | 7/7/2023 | Pending | Common Observation Policy | |
2023-UHC-247 |
|
5/26/23 | 7/10/23 | Approved | Negative Pressure Wound Therapy | |
2023-LHCC-336 | Care Management Program Description | 5/26/23 | 7/10/23 | Approved | Care Management Program Description | |
2023-UHC-474 | Rhinoplasty and Other Nasal Procedures | 5/26/23 | 7/10/23 | Approved | Rhinoplasty and Other Nasal Procedures | |
2023-UHC-492 | Surgical and Ablative Procedures for Venous Insufficiency and Varicose Veins | 5/26/23 | 7/10/23 | Approved | Surgical and Ablative Procedures for Venous Insufficiency and Varicose Veins | |
2023-UHC-520 | Panniculectomy Body Contouring Procedures | 5/26/23 | 7/10/23 | Approved | Panniculectomy Body Contouring Procedures | |
2023-UHC-555 | Orthognathic (Jaw) Surgery | 5/26/23 | 7/10/23 | Approved | Orthognathic (Jaw) Surgery | |
2023-UHC-586 | Chelation Therapy | 5/26/23 | 7/10/23 | Approved | Chelation Therapy | |
2023-UHC-783 | Electrical Bioimpedance for Cardiac Output Measurement | 5/26/23 | 7/10/23 | Approved | Electrical Bioimpedance for Cardiac Output Measurement | |
2023-ABH-822 | ABH Provider Manual | 5/26/23 | 7/10/23 | Approved | ABH Provider Manual | |
2023-UHC-949 | Chemotherapy-Observation or Inpatient Hospitalization | 5/26/23 | 7/10/23 | Approved | Chemotherapy-Observation or Inpatient Hospitalization | |
2023-LHCC-966 | Cultural and Linguistic Policy | 5/26/23 | 7/10/23 | Approved | Cultural and Linguistic Policy | |
2023-ABH-1174 | Applied Behavior Analysis | 5/26/23 | 7/10/23 | Approved | Applied Behavior Analysis | |
2023-UHC-1340 | Gynecomastia Surgery | 5/26/23 | 7/10/23 | Approved | Gynecomastia Surgery | |
2023-UHC-1342 | Pectus Deformity Repair | 5/26/23 | 7/10/23 | Approved | Pectus Deformity Repair | |
2023-UHC-1350 | Gender Dysphoria Treatment | 5/26/23 | 7/10/23 | Approved | Gender Dysphoria Treatment | |
2023-UHC-1392 | Gastrointestinal Motility Disorders | 5/26/23 | 7/10/23 | Approved | Gastrointestinal Motility Disorders | |
2023-UHC-1395 | Motorized Spinal Traction | 5/26/23 | 7/10/23 | Approved | Motorized Spinal Traction | |
2023-ABH-1528 | Substance Use Disorder Treatment - Intensive Outpatient and Residential LOC | 5/26/23 | 7/10/23 | Approved | Substance Use Disorder Treatment - Intensive Outpatient and Residential LOC | |
2023-ABH-1930 | Eye Vendor - Provider Manual | 5/26/23 | 7/10/23 | Approved | Eye Vendor - Provider Manual | |
2023-LHCC-1933 | Personal Care Services (PCS) | 5/26/23 | 7/10/23 | Approved | Personal Care Services (PCS) | |
2023-Humana-1936 | Humana Code Edit - Outpatient Services while Inpatient | 5/26/23 | 7/10/23 | Approved | Humana Code Edit - Outpatient Services while Inpatient | |
2023-UHC-1941 | Louisiana ABA Policy | 5/26/23 | 7/10/23 | Approved | Louisiana ABA Policy | |
2023-UHC-486 | Abnormal Uterine Bleeding and Uterine Fibroids | 6/7/23 | 7/5/23 | withdrawn | Abnormal Uterine Bleeding and Uterine Fibroids | |
2023-UHC-1523 | Facet Joint and Medial Branch Block Injections for Spinal Pain | 5/26/23 | 7/5/23 | Withdrawn | Facet Joint and Medial Branch Block Injections for Spinal Pain | |
2023-LHCC-1218 | Ventricular Assist Devices | 6/5/23 | 7/20/23 | Withdrawn | Ventricular Assist Devices | |
2023-UHC-217 | Omnibus Codes | 5/5/23 | 6/19/23 | Approved | Omnibus Codes | |
2023-UHC-490 | Cardiovascular Disease Risk Tests | 5/5/23 | 6/19/23 | Approved | Cardiovascular Disease Risk Tests | |
2023-UHC-1170 | Prostate Surgeries and Interventions | 5/5/23 | 6/19/23 | Approved | Prostate Surgeries and Interventions | |
2023-UHC-1367 | Patient Lifts | 5/5/23 | 6/19/23 | Approved | Patient Lifts | |
2023-Humana-1857 | Multiple Initial Hospital Care Services | 5/5/23 | 6/19/23 | Approved | Multiple Initial Hospital Care Services | |
2023-LHCC-1916 | Individual Placement and Support | 5/5/23 | 6/19/23 | Approved | Individual Placement and Support | |
2023-Humana-1923 | Pregnant SUD ILOS | 5/5/23 | 6/19/23 | Approved | Pregnant SUD ILOS | |
2023-UHC-1931 | Fecal Microbiota Transplantation | 5/5/23 | 6/19/23 | Approved | Fecal Microbiota Transplantation | |
2023-UHC-1932 | Corneal Collagen Cross-Linking | 5/5/23 | 6/19/23 | Approved | Corneal Collagen Cross-Linking | |
2023-UHC-222 | Skin and Soft Tissue Substitutes | 5/2/23 | 6/16/23 | Approved | Skin and Soft Tissue Substitutes | |
2023-UHC-375 | Pneumatic Compression Devices | 5/2/23 | 6/16/23 | Approved | Pneumatic Compression Devices | |
2023-UHC-379 | Brow Ptosis and Eyelid Repair | 5/2/23 | 6/16/23 | Approved | Brow Ptosis and Eyelid Repair | |
2023-UHC-482 | Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions | 5/2/23 | 6/16/23 | Approved | Molecular Oncology Testing for Cancer Diagnosis, Prognosis, and Treatment Decisions | |
2023-UHC-578 | Thermography | 5/2/23 | 6/16/23 | Approved | Thermography | |
2023-LHCC-682 | Active Procedures in Physical Medicine | 5/2/23 | 6/16/23 | Approved | Active Procedures in Physical Medicine | |
2023-LHCC-685 | Experimental, Unproven, or Investigational Services | 5/2/23 | 6/16/23 | Approved | Experimental, Unproven, or Investigational Services | |
2023-LHCC-687 | Measurable Progressive Improvement | 5/2/23 | 6/16/23 | Approved | Measurable Progressive Improvement | |
2023-LHCC-689 | Outpatient Habilitative PT and OT Therapy Final | 5/2/23 | 6/16/23 | Approved | Outpatient Habilitative PT and OT Therapy Final | |
2023-LHCC-690 | Outpatient Habilitative Speech Therapy | 5/2/23 | 6/16/23 | Approved | Outpatient Habilitative Speech Therapy | |
2023-LHCC-691 | Passive Treatment | 5/2/23 | 6/16/23 | Approved | Passive Treatment | |
2023-UHC-825 | Cardiac Event Monitoring | 5/2/23 | 6/16/23 | Approved | Cardiac Event Monitoring | |
2023-HBL-986 | Diagnostic Coronary Angiography | 5/2/23 | 6/16/23 | Approved | Diagnostic Coronary Angiography | |
2023-HBL-1009 | Advanced Imaging of the Heart | 5/2/23 | 6/16/23 | Approved | Advanced Imaging of the Heart | |
2023-HBL-1058 | Whole Genome Sequ. Whole Exome Sequ. Gene Panels and Molecular Prof | 5/2/23 | 6/16/23 | Approved | Whole Genome Sequ. Whole Exome Sequ. Gene Panels and Molecular Prof | |
2023-HBL-1250 | Radiation Oncology | 5/2/23 | 6/16/23 | Approved | Radiation Oncology | |
2023-LHCC-1275 | Oxygen Use and Concentrators | 5/2/23 | 6/16/23 | Approved | Oxygen Use and Concentrators | |
2023-UHC-1371 | Athletic Pubalgia Surgery | 5/2/23 | 6/16/23 | Approved | Athletic Pubalgia Surgery | |
2023-UHC-1394 | Transpupillary Thermotherapy | 5/2/23 | 6/16/23 | Approved | Transpupillary Thermotherapy | |
2023-LHCC-1430 | Record Keeping and Documentation Standards: Physical Medicine | 5/2/23 | 6/16/23 | Approved | Record Keeping and Documentation Standards: Physical Medicine | |
2023-UHC-1816 | Enteral Nutrition (Oral and Tube Feeding) | 5/2/23 | 6/16/23 | Approved | Enteral Nutrition (Oral and Tube Feeding) | |
2023-ABH-1900 | Physical Safety for Field Based Colleagues | 5/2/23 | 6/16/23 | Complete | Physical Safety for Field Based Colleagues | |
2023-LHCC-1909 | Peer Support Services | 5/2/23 | 6/16/23 | Approved | Peer Support Services | |
2023-LHCC-1910 | Implantable Intrathecal or Epidural Pain Pump | 5/2/23 | 6/16/23 | Approved | Implantable Intrathecal or Epidural Pain Pump | |
2023-LHCC-1911 | Ambulatory Surgery Center Optimization | 5/2/23 | 6/16/23 | Approved | Ambulatory Surgery Center Optimization | |
2023-LHCC-1912 | Multi-Systemic Therapy (MST) | 5/2/23 | 6/16/23 | Approved | Multi-Systemic Therapy (MST) | |
2023-Humana-1914 | Louisiana Medicaid Occurrence Date | 5/2/23 | 6/16/23 | Approved | Louisiana Medicaid Occurrence Date | |
2023-LHCC-1915 | E&M Services billed with Treatment Room Rev Code | 5/2/23 | 6/16/23 | Approved | E&M Services billed with Treatment Room Rev Code | |
2023-UHC-1928 | Transanal Endoscopic Microsurgery | 5/2/23 | 6/16/23 | Approved | Transanal Endoscopic Microsurgery | |
2023-LDH-4 | MCO Manual > Part 4: Services > Pharmacy (Proposed effective date = 10/1/2023) |
4/26/23 | 6/10/23 | Completed | Pharmacy | |
2023-LDH-3 | MCO Manual > Part 4: Services > Professional Services > Obstetrics (Effective date = 4/6/2023) | 4/26/23 | NA | Completed | Obstetrics – Alpha Hydroxyprogesterone Caproate Imminent Peril Justification |
|
2023-Humana-1531 | ABA Clinical Coverage | 4/18/23 | 6/2/23 | Approved | ABA Clinical Coverage | |
2023-Humana-1739 | NEMT Meals and Lodging | 4/18/23 | 6/2/23 | Approved | NEMT Meals and Lodging | |
2023-Humana-1740 | NEMT Geo Access Standards | 4/18/23 | 6/2/23 | Approved | NEMT Geo Access Standards | |
2023-ABH-1765 | NEMT - Non-emergency Medical Transportation | 4/18/23 | 6/2/23 | Approved | NEMT - Non-emergency Medical Transportation | |
2023-ABH-1899 | Prenatal Services | 4/18/23 | 6/2/23 | Approved | Prenatal Services | |
2023-LHCC-1902 | Cosmetic Procedures | 4/18/23 | 6/2/23 | Approved | Cosmetic Procedures | |
2023-LHCC-1917 | Repair of Nasal Valve Compromise | 4/18/23 | 6/2/23 | Approved | Repair of Nasal Valve Compromise | |
2023-LHCC-24 | Advance Directives | 4/14/23 | 5/29/23 | Complete | Advance Directives | |
2023-LHCC-129 | Provider Directory and Electronic Files from Portico | 4/14/23 | 5/29/23 | Complete | Provider Directory and Electronic Files from Portico | |
2023-LHCC-419 | Provider Termination | 4/14/23 | 5/29/23 | Complete | Provider Termination | |
2023-LHCC-422 | Network Development and Management | 4/14/23 | 5/29/23 | Complete | Network Development and Management | |
2023-LHCC-430 | Covered Benefits and Services | 4/14/23 | 5/29/23 | Complete | Covered Benefits and Services | |
2023-LHCC-680 | Provider Reimbursement | 4/14/23 | 5/29/23 | Complete | Provider Reimbursement | |
2023-LHCC-829 | Interrater Reliability - Act 421 | 4/14/23 | 5/29/23 | Complete | Interrater Reliability - Act 421 | |
2023-LHCC-910 | Network Selection and Retention | 4/14/23 | 5/29/23 | Complete | Network Selection and Retention | |
2023-LHCC-916 | Case Management Assessment Process | 4/14/23 | 5/29/23 | Complete | Case Management Assessment Process | |
2023-LHCC-925 | Provider Complaints | 4/14/23 | 5/29/23 | Complete | Provider Complaints | |
2023-LHCC-963 | Claims Management-Payment to Provider | 4/14/23 | 5/29/23 | Complete | Claims Management-Payment to Provider | |
2023-LHCC-982 | Outpatient Applied Behavior Analysis Medical Necessity | 4/14/23 | 5/29/23 | Approved | Outpatient Applied Behavior Analysis Medical Necessity | |
2023-LHCC-994 | Ambulatory Insulin Pump | 4/14/23 | 5/29/23 | Approved | Ambulatory Insulin Pump | |
2023-LHCC-1769 | Abuse and Neglect Reporting | 4/14/23 | 5/29/23 | Complete | Abuse and Neglect Reporting | |
2023-UHC-1798 | Case Management Process | 4/14/23 | 5/29/23 | Complete | Case Management Process | |
2023-LHCC-1875 | Ongoing Monitoring of Sanctions & Complaints | 4/14/23 | 5/29/23 | Complete | Ongoing Monitoring of Sanctions & Complaints | |
2023-LHCC-1876 | Practitioner Disciplinary Action and Reporting | 4/14/23 | 5/29/23 | Complete | Practitioner Disciplinary Action and Reporting | |
2023-LHCC-1877 | Provider Directory for Members | 4/14/23 | 5/29/23 | Complete | Provider Directory for Members | |
2023-ABH-1893 | Provider Disputes | 4/14/23 | 5/29/23 | Complete | Provider Disputes | |
2023-ABH-1894 | Provider Complaints | 4/14/23 | 5/29/23 | Complete | Provider Complaints | |
2023-LHCC-111 | Functional Family Therapy - Child Welfare | 4/10/23 | 5/25/23 | Complete | Functional Family Therapy - Child Welfare | |
2023-Humana-1532 | Assertive Community Treatment (ACT/FACT) | 4/10/23 | 5/25/23 | Approved | Assertive Community Treatment (ACT/FACT) | |
2023-UHC-1719 | Louisiana BH Supplemental Clinical Care | 4/10/23 | 5/25/23 | Approved | Louisiana BH Supplemental Clinical Care | |
2023-UHC-1804 | Policy Submissions to LDH | 4/10/23 | 5/25/23 | Complete | Policy Submissions to LDH | |
2023-UHC-1805 | Transition of Care Coordination | 4/10/23 | 5/25/23 | Complete | Transition of Care Coordination | |
2023-UHC-1811 | Integration of Physical Health Through Whole Person Care | 4/10/23 | 5/25/23 | Complete | Integration of Physical Health Through Whole Person Care | |
2023-LHCC-1843 | Extended Home Health Services | 4/10/23 | 5/25/23 | Approved | Extended Home Health Services | |
2023-LHCC-1872 | Retroactive Reimbursement | 4/10/23 | 5/25/23 | Approved | Retroactive Reimbursement | |
2023-ACLA-1895 | Chiropractic ILOS | 4/10/23 | 5/25/23 | Approved | Chiropractic ILOS | |
2023-ACLA-1896 | Doula ILOS | 4/10/23 | 5/25/23 | Approved | Doula ILOS | |
2023-ACLA-1897 | Remote Patient Monitoring ILOS | 4/10/23 | 5/25/23 | Approved | Remote Patient Monitoring ILOS | |
2023-LHCC-1903 | Renal Hemodialysis | 4/10/23 | 5/25/23 | Approved | Renal Hemodialysis | |
2023-LHCC-1904 | Homebuilder Services | 4/10/23 | 5/25/23 | Approved | Homebuilder Services | |
2023-LHCC-1905 | Stereotactic Body Radiation Therapy | 4/10/23 | 5/25/23 | Pending | Stereotactic Body Radiation Therapy | |
2023-LHCC-1907 | Hyperhidrosis Treatments | 4/10/23 | 5/25/23 | Approved | Hyperhidrosis Treatments | |
2023-LHCC-1906 | Sleep Center Polysomnography and Split-Night Studies for OSA | 4/10/23 | 5/25/23 | Withdrawn | Sleep Center Polysomnography and Split-Night Studies for OSA | |
2023-UHC-1761 | Home Health | 3/31/23 | 5/15/23 | Approved | Home Health | |
2023-Humana-1854 | Rebundling | 3/31/23 | 5/15/23 | Approved | Rebundling | |
2023-Humana-1855 | External Cause Diagnosis Codes | 3/31/23 | 5/15/23 | Complete | External Cause Diagnosis Codes | |
2023-Humana-1856 | Modifier JW – Drug Waste | 3/31/23 | 5/15/23 | Complete | Modifier JW – Drug Waste | |
2023-ACLA-1874 | Adverse Incident Reporting | 3/31/23 | 5/15/23 | Approved | Adverse Incident Reporting | |
2023-ABH-1892 | Member Grievance | 3/31/23 | 5/15/23 | Approved | Member Grievance | |
2023-ABH-1901 | Reporting Abuse, Neglect, and Exploitation | 3/31/23 | 5/15/23 | Approved | Reporting Abuse, Neglect, and Exploitation | |
2023-LDH-2 | MCO Manual > Part 4: Services > Hospital Services > Inpatient Hospital Services (Proposed effective date = 1/1/2023) | 3/31/23 | 5/15/23 | Approved | Rapid Whole Genome Sequencing of Critically Ill Infants | |
2023-LHCC-1363 | Tandem Transplant | 4/10/23 | 5/12/23 | Withdrawn | Tandem Transplant | |
2023-LDH-1 | MCO Manual > Part 4: Services > In Lieu of Services > Physical Health Services (Proposed effective date = 2/9/2023) | 3/24/23 | 5/8/23 | Approved | Remote Patient Monitoring | |
2023-UHC-524 | DME, Orthotics, Medical Supplies and Repairs/Replacements | 3/24/23 | 5/8/23 | Approved | DME, Orthotics, Medical Supplies and Repairs/Replacements | |
2023-ACLA-872 | CT Coronary Angiography (CCTA) | 3/24/23 | 5/8/23 | Approved | CT Coronary Angiography (CCTA) | |
2023-LHCC-911 | Network Adequacy | 3/24/23 | 5/8/23 | Approved | Network Adequacy | |
2023-ABH-1289 | Mental Health Intensive Outpatient | 3/24/23 | 5/8/23 | Complete | Mental Health Intensive Outpatient | |
2023-LHCC-1389 | Endometrial Ablation | 3/24/23 | 5/8/23 | Approved | Endometrial Ablation | |
2023-UHC-1849 | Upper Extremity Myoelectric Prosthetic Devices | 3/24/23 | 5/8/23 | Approved | Upper Extremity Myoelectric Prosthetic Devices | |
2023-UHC-1873 | Lower Extremity Prosthetics | 3/24/23 | 5/8/23 | Approved | Lower Extremity Prosthetics | |
2023-ABH-1891 | Member Appeals | 3/24/23 | 5/8/23 | Approved | Member Appeals | |
2023-ABH-1898 | Case Rounds | 3/24/23 | 5/8/23 | Approved | Case Rounds | |
2023-ACLA-1864 | Speech Therapy | 3/16/23 | 4/30/23 | Approved | Speech Therapy | |
2023-ACLA-1865 | Pancreas Transplantation | 3/16/23 | 4/30/23 | Approved | Pancreas Transplantation | |
2023-ACLA-1866 | Gastroparesis Evaluations | 3/16/23 | 4/30/23 | Approved | Gastroparesis Evaluations | |
2023-ACLA-1868 | Electrical Muscle Stimulation | 3/16/23 | 4/30/23 | Approved | Electrical Muscle Stimulation | |
2023-ACLA-1871 | Three dimensional imaging interpretation | 3/16/23 | 4/30/23 | Approved | Three dimensional imaging interpretation | |
2023-LHCC-1878 | Cervical Spine Surgery | 3/16/23 | 4/30/23 | Approved | Cervical Spine Surgery | |
2023-LHCC-1879 | Deformity Surgery | 3/16/23 | 4/30/23 | Approved | Deformity Surgery | |
2023-LHCC-1880 | Hip Arthroplasty | 3/16/23 | 4/30/23 | Approved | Hip Arthroplasty | |
2023-LHCC-1881 | Hip Arthroscopy | 3/16/23 | 4/30/23 | Approved | Hip Arthroscopy | |
2023-LHCC-1882 | Knee Arthroplasty | 3/16/23 | 4/30/23 | Approved | Knee Arthroplasty | |
2023-LHCC-1883 | Lumbar Artificial Disc Replacement | 3/16/23 | 4/30/23 | Approved | Lumbar Artificial Disc Replacement | |
2023-LHCC-1884 | Lumbar Spine Surgery | 3/16/23 | 4/30/23 | Approved | Lumbar Spine Surgery | |
2023-LHCC-1885 | Knee Arthroscopy | 3/16/23 | 4/30/23 | Approved | Knee Arthroscopy | |
2023-LHCC-1886 | Sacroiliac Joint Infusion | 3/16/23 | 4/30/23 | Approved | Sacroiliac Joint Infusion | |
2023-LHCC-1887 | Shoulder Arthroplasty | 3/16/23 | 4/30/23 | Approved | Shoulder Arthroplasty | |
2023-LHCC-1888 | Spine Surgery Other | 3/16/23 | 4/30/23 | Approved | Spine Surgery Other | |
2023-LHCC-1889 | Shoulder Arthroscopy | 3/16/23 | 4/30/23 | Approved | Shoulder Arthroscopy | |
2023-LHCC-1890 | Thoracic Spine Surgery | 3/16/23 | 4/30/23 | Approved | Thoracic Spine Surgery | |
2023-LHCC-679 | Claims Management /Claims Processing | 3/16/23 | 4/30/23 | Approved | Claims Management /Claims Processing | |
2023-LHCC-692 | Claims Management Reporting and Auditing | 3/16/23 | 4/30/23 | Approved | Claims Management Reporting and Auditing | |
2023-LHCC-932 | Potential QOC Incidents Policy | 3/16/23 | 4/30/23 | Approved | Potential QOC Incidents Policy | |
2023-LHCC-962 | Claims Management Functionality | 3/16/23 | 4/30/23 | Approved | Claims Management Functionality | |
2023-UHC-1178 | Liposuction for Lipedema | 3/16/23 | 4/30/23 | Approved | Liposuction for Lipedema | |
2023-Humana-1590 | Chiropractic ILOS | 3/16/23 | 4/30/23 | Approved | Chiropractic ILOS | |
2023-Humana-1818 | Functional Family Therapy (FFT) | 3/16/23 | 4/30/23 | Approved | Functional Family Therapy (FFT) | |
2023-Humana-1826 | Revenue Codes for Outpatient Services | 3/16/23 | 4/30/23 | Approved | Revenue Codes for Outpatient Services | |
2023-LHCC-1833 | Assertive Community Treatment (ACT) | 3/16/23 | 4/30/23 | Approved | Assertive Community Treatment (ACT) | |
2023-LHCC-1845 | PDHC Policy | 3/16/23 | 4/30/23 | Approved | PDHC Policy | |
2023-UHC-1851 | Whole Exome and Whole Genome Sequencing | 3/16/23 | 4/30/23 | Approved | Whole Exome and Whole Genome Sequencing | |
2023-UHC-1852 | Macular Degeneration Treatment Procedures | 3/16/23 | 4/30/23 | Approved | Macular Degeneration Treatment Procedures | |
2023-ACLA-1859 | Nonpharmacologic treatments for chronic vertigo | 3/16/23 | 4/30/23 | Approved | Nonpharmacologic treatments for chronic vertigo | |
2023-ACLA-1860 | Phototherapy & Photochemotherapy for skin conditions | 3/16/23 | 4/30/23 | Approved | Phototherapy & Photochemotherapy for skin conditions | |
2023-ACLA-1861 | Lung Transplants | 3/16/23 | 4/30/23 | Approved | Lung Transplants | |
2023-ACLA-1863 | Excimer laser for Vitiligo | 3/16/23 | 4/30/23 | Approved | Excimer laser for Vitiligo | |
2023-UHC-311 | Transcatheter Heart Valve Procedures | 3/7/23 | 4/21/23 | Approved | Transcatheter Heart Valve Procedures | |
2023-LHCC-432 | Psychiatric Treatment Facility | 3/7/23 | 4/21/23 | Approved | Psychiatric Treatment Facility | |
2023-UHC-491 | Electrical Stimulation And Electromagnetic Therapy For Wounds | 3/7/23 | 4/21/23 | Approved | Electrical Stimulation And Electromagnetic Therapy For Wounds | |
2023-UHC-511 | Manipulation Under Anesthesia | 3/7/23 | 4/21/23 | Approved | Manipulation Under Anesthesia | |
2023-UHC-580 | Embolization Ovarian Iliac Pelvic Congestion Syndrome | 3/7/23 | 4/21/23 | Approved | Embolization Ovarian Iliac Pelvic Congestion Syndrome | |
2023-UHC-961 | Elective Inpatient Services | 3/7/23 | 4/21/23 | Approved | Elective Inpatient Services | |
2023-UHC-1458 | Hepatitis Screening | 3/7/23 | 4/21/23 | Approved | Hepatitis Screening | |
2023-ABH-1529 | Abortion Procedures | 3/7/23 | 4/21/23 | Approved | Abortion Procedures | |
2023-UHC-1846 | Interspinous Fusion and Decompression Devices | 3/7/23 | 4/21/23 | Approved | Interspinous Fusion and Decompression Devices | |
2023-UHC-1847 | Spinal Fusion and Decompression | 3/7/23 | 4/21/23 | Approved | Spinal Fusion and Decompression | |
2023-HBL-586 | Global Surgical Package Reimbursement Policy | 3/1/23 | 4/15/23 | Approved | Global Surgical Package Reimbursement Policy | |
2023-LHCC-712 | CT Coronary Angiography (CCTA) | 3/1/23 | 4/15/23 | Approved | CT Coronary Angiography (CCTA) | |
2023-Humana-1548 | Individual Placement and Support (IPS) | 3/1/23 | 4/15/23 | Approved | Individual Placement and Support (IPS) | |
2023-Humana-1561 | Multi-Systemic Therapy (MST) | 3/1/23 | 4/15/23 | Approved | Multi-Systemic Therapy (MST) | |
2023-LHCC-1835 | Continuous Glucose Monitors | 3/1/23 | 4/15/23 | Approved | Continuous Glucose Monitors | |
2023-LHCC-1840 | Cochlear Implants and Replacements | 3/1/23 | 4/15/23 | Approved | Cochlear Implants and Replacements | |
2023-LHCC-1841 | MNC Policy for CPST and PSR | 3/1/23 | 4/15/23 | Denied | MNC Policy for CPST and PSR | |
2023-LHCC-1842 | Cosmetic and Reconstructive Procedures | 3/1/23 | 4/15/23 | Approved | Cosmetic and Reconstructive Procedures | |
2023-LHCC-1844 | Transplant Service Documentation Requirements | 3/1/23 | 4/15/23 | Approved | Transplant Service Documentation Requirements | |
2023-UHC-312 | Intensity Modulated Radiation Therapy | 2/23/23 | 4/9/23 | Approved | Intensity Modulated Radiation Therapy | |
2023-UHC-377 | Implanted Electrical Stimulator for Spinal Cord | 2/23/23 | 4/9/23 | Approved | Implanted Electrical Stimulator for Spinal Cord | |
2023-LHCC-426 | Adverse Incidents | 2/23/23 | 4/9/23 | Approved | Adverse Incidents | |
2023-UHC-557 | Transcranial Magnetic Stimulation | 2/23/23 | 4/9/23 | Approved | Transcranial Magnetic Stimulation | |
2023-UHC-782 | Discogenic Pain Treatment | 2/23/23 | 4/9/23 | Approved | Discogenic Pain Treatment | |
2023-UHC-785 | Hearing Aids and Devices including wearable, bone-anchored and semi-implantable | 2/23/23 | 4/9/23 | Approved | Hearing Aids and Devices including wearable, bone-anchored and semi-implantable | |
2023-UHC-828 | Minimally Invasive Spine Surgery Procedures | 2/23/23 | 4/9/23 | Approved | Minimally Invasive Spine Surgery Procedures | |
2023-LHCC-1109 | Diaphragmatic/Phrenic Nerve Stimulation | 2/23/23 | 4/9/23 | Approved | Diaphragmatic/Phrenic Nerve Stimulation | |
2023-LHCC-1211 | Reduction Mammoplasty and Gynecomastia Surgery | 2/23/23 | 4/9/23 | Approved | Reduction Mammoplasty and Gynecomastia Surgery | |
2023-LHCC-1361 | Pediatric Heart Transplant | 2/23/23 | 4/9/23 | Approved | Pediatric Heart Transplant | |
2023-Humana-1540 | Crisis Stabilization Services for Adults | 2/23/23 | 4/9/23 | Approved | Crisis Stabilization Services for Adults | |
2023-UHC-1830 | Hysterectomy | 2/23/23 | 4/9/23 | Approved | Hysterectomy | |
2023-LHCC-1831 | Bilateral Procedures | 2/23/23 | 4/9/23 | Completed | Bilateral Procedures | |
2023-LHCC-1832 | Vitmin D Testing Policy | 2/23/23 | 4/9/23 | Approved | Vitmin D Testing Policy | |
2023-LHCC-1834 | Enteral Nutrition | 2/23/23 | 4/9/23 | Approved | Enteral Nutrition | |
2023-LHCC-1836 | CLIA Editing | 2/23/23 | 4/9/23 | Completed | CLIA Editing | |
2023-LHCC-1837 | Obstetrical Home Care Programs | 2/23/23 | 4/9/23 | Approved | Obstetrical Home Care Programs | |
2023-LHCC-1838 | Intensity-Modulated Radiotherapy | 2/23/23 | 4/9/23 | Approved | Intensity-Modulated Radiotherapy | |
2023-LHCC-1839 | Genetic Testing Hereditary Cancer Susceptibility | 2/23/23 | 4/9/23 | Approved | Genetic Testing Hereditary Cancer Susceptibility | |
2023-LHCC-920 | Member ID Cards | 2/20/23 | 4/6/23 | Approved | Member ID Cards | |
2023-LHCC-1449 | Practitioner Credentialing and Recredentialing | 2/20/23 | 4/6/23 | Approved | Practitioner Credentialing and Recredentialing | |
2023-LHCC-1516 | Oversight of Delegated Credentialing | 2/20/23 | 4/6/23 | Approved | Oversight of Delegated Credentialing | |
2023-LHCC-1588 | Member Advisory of Provider Contract Termination or Limitation Policy | 2/20/23 | 4/6/23 | Completed | Member Advisory of Provider Contract Termination or Limitation Policy | |
2023-LHCC-1770 | Provider Marketing Guidelines | 2/20/23 | 4/6/23 | Approved | Provider Marketing Guidelines | |
2023-LHCC-1771 | Allowable Marketing Activities | 2/20/23 | 4/6/23 | Approved | Allowable Marketing Activities | |
2023-LHCC-1772 | Notice to Members of Provider Terminations | 2/20/23 | 4/6/23 | Approved | Notice to Members of Provider Terminations | |
2023-LHCC-1773 | Written Material Guidelines | 2/20/23 | 4/6/23 | Approved | Written Material Guidelines | |
2023-LHCC-1774 | Pharmacy-Related Marketing and Enrollee Education | 2/20/23 | 4/6/23 | Approved | Pharmacy-Related Marketing and Enrollee Education | |
2023-LHCC-1775 | Interpretation and Written Translation Services | 2/20/23 | 4/6/23 | Approved | Interpretation and Written Translation Services | |
2023-LHCC-1776 | Web and Mobile Based Enrollee Applications | 2/20/23 | 4/6/23 | Approved | Web and Mobile Based Enrollee Applications | |
2023-UHC-207 | Electrical Stimulation for the Treatment of Pain and Muscle Rehabilitation | 2/15/23 | 4/1/23 | Approved | Electrical Stimulation for the Treatment of Pain and Muscle Rehabilitation | |
2023-UHC-219 | Articular Defect Repairs | 2/15/23 | 4/1/23 | Approved | Articular Defect Repairs | |
2023-UHC-510 | Collagen Crosslinks and Biochemical Markers of Bone Turnover | 2/15/23 | 4/1/23 | Approved | Collagen Crosslinks and Biochemical Markers of Bone Turnover | |
2023-LHCC-814 | Crisis Intervention Policy | 2/15/23 | 4/1/23 | Approved | Crisis Intervention Policy | |
2023-LHCC-1217 | Ultrasound in Pregnancy | 2/15/23 | 4/1/23 | Approved | Ultrasound in Pregnancy | |
2023-LHCC-1227 | Skin Substitutes for Chronic Wounds | 2/15/23 | 4/1/23 | Approved | Skin Substitutes for Chronic Wounds | |
2023-LHCC-1270 | Urinary Incontinence Devices and Treatments | 2/15/23 | 4/1/23 | Approved | Urinary Incontinence Devices and Treatments | |
2023-LHCC-1271 | Implantable Hypoglossal Nerve Stimulation for OSA | 2/15/23 | 4/1/23 | Approved | Implantable Hypoglossal Nerve Stimulation for OSA | |
2023-HBL-1338 | Duplicate or Subsequent Services on the Same Day of Service RP | 2/15/23 | 4/1/23 | Approved | Duplicate or Subsequent Services on the Same Day of Service RP | |
2023-LHCC-1365 | GI Pathogen Nucleic Acid and Detection Panel Testing | 2/15/23 | 4/1/23 | Approved | GI Pathogen Nucleic Acid and Detection Panel Testing | |
2023-Humana-1531 | ABA Clinical Coverage | 2/15/23 | 4/1/23 | Approved | ABA Clinical Coverage | |
2023-Humana-1537 | Mental Health Rehabilitation Services - Community Psychiatric Support and Treatment (CPST) and Psychosocial Rehabilitation (PSR) | 2/15/23 | 4/1/23 | Approved | Mental Health Rehabilitation Services - Community Psychiatric Support and Treatment (CPST) and Psychosocial Rehabilitation (PSR) | |
2023-Humana-1814 | Code Edit – ASC | 2/15/23 | 4/1/23 | Approved | Code Edit – ASC | |
2023-LHCC-1819 | Burn Surgery | 2/15/23 | 4/1/23 | Approved | Burn Surgery | |
2023-LHCC-1820 | Transcatheter Closure of Patent Foramen Ovale | 2/15/23 | 4/1/23 | Approved | Transcatheter Closure of Patent Foramen Ovale | |
2023-LHCC-1821 | Selective Dorsal Rhizotomy for Spasticity in CP | 2/15/23 | 4/1/23 | Approved | Selective Dorsal Rhizotomy for Spasticity in CP | |
2023-LHCC-1822 | Opioid Use Disorder (OUD) treatment in Opioid Treatment Programs | 2/15/23 | 4/1/23 | Approved | Opioid Use Disorder (OUD) treatment in Opioid Treatment Programs | |
2023-LHCC-1823 | Mechanical Stretch devices | 2/15/23 | 4/1/23 | Approved | Mechanical Stretch devices | |
2023-LHCC-1824 | Electric Tumor Treatment Fields | 2/15/23 | 4/1/23 | Approved | Electric Tumor Treatment Fields | |
2023-LHCC-1825 | Proton and Neutron Beam Therapies | 2/15/23 | 4/1/23 | Approved | Proton and Neutron Beam Therapies | |
2023-UHC-1829 | Pharmacognetic Panel Testing | 2/15/23 | 4/1/23 | Approved | Pharmacognetic Panel Testing | |
2023-LHCC-776 | Transesophageal (TEE) Echo | 2/14/23 | 3/31/23 | Approved | Transesophageal (TEE) Echo | |
2023-HBL-1435 | Opthalmic use of Nd:YAG Laser for Posterior Capsulotomy | 2/14/23 | 3/31/23 | Approved | Opthalmic use of Nd:YAG Laser for Posterior Capsulotomy | |
2023-LHCC-1487 | Sleep Studies Place of Service | 2/14/23 | 3/31/23 | Approved | Sleep Studies Place of Service | |
2023-HBL-1715 | Permanent Support Housing | 2/14/23 | 3/31/23 | Approved | Permanent Support Housing | |
2023-LHCC-1741 | AHCT for Sickle Cell Anemia and Thalassemia | 2/14/23 | 3/31/23 | Approved | AHCT for Sickle Cell Anemia and Thalassemia | |
2023-LHCC-1742 | Ferriscan R2 MRI | 2/14/23 | 3/31/23 | Approved | Ferriscan R2 MRI | |
2023-LHCC-1743 | Hospice Services | 2/14/23 | 3/31/23 | Approved | Hospice Services | |
2023-LHCC-1744 | Phototherapy for Neonatal Hyperbilirubinemia | 2/14/23 | 3/31/23 | Approved | Phototherapy for Neonatal Hyperbilirubinemia | |
2023-LHCC-1745 | Donor Lymphocyte Infusion | 2/14/23 | 3/31/23 | Approved | Donor Lymphocyte Infusion | |
2023-LHCC-1746 | Total Artificial Heart | 2/14/23 | 3/31/23 | Approved | Total Artificial Heart | |
2023-LHCC-1747 | PCS-EPSDT Policy | 2/14/23 | 3/31/23 | Approved | PCS-EPSDT Policy | |
2023-ABH-1748 | Interdisciplinary Care Team | 2/14/23 | 3/31/23 | Complete | Interdisciplinary Care Team | |
2023-HBL-1749 | Gene Therapy for Hemophilia | 2/14/23 | 3/31/23 | Approved | Gene Therapy for Hemophilia | |
2023-LHCC-1750 | Sacroiliac Joint Injections – NIA | 2/14/23 | 3/31/23 | Approved | Sacroiliac Joint Injections – NIA | |
2023-LHCC-1751 | Spinal Cord Stimulation – NIA | 2/14/23 | 3/31/23 | Approved | Spinal Cord Stimulation – NIA | |
2023-LHCC-1752 | Epidural Spine Injections – NIA | 2/14/23 | 3/31/23 | Approved | Epidural Spine Injections – NIA | |
2023-LHCC-1753 | Implantable Infusion Pump Insertion – NIA | 2/14/23 | 3/31/23 | Approved | Implantable Infusion Pump Insertion – NIA | |
2023-LHCC-1754 | Epidural Spine Injection Trial Intrathecal Hybrid – NIA | 2/14/23 | 3/31/23 | Approved | Epidural Spine Injection Trial Intrathecal Hybrid – NIA | |
2023-LHCC-1755 | Facet Injection or Blocks - NIA | 2/14/23 | 3/31/23 | Approved | Facet Injection or Blocks - NIA | |
2023-UHC-222 | Skin and Soft Tissue Substitutes | 2/7/23 | 3/24/23 | Approved | Skin and Soft Tissue Substitutes | |
2023-UHC-223 | Vagus and External Trigeminal Nerve Stimulation | 2/7/23 | 3/24/23 | Approved | Vagus and External Trigeminal Nerve Stimulation | |
2023-UHC-310 | Total Artificial Disc Replacement Spine | 2/7/23 | 3/24/23 | Approved | Total Artificial Disc Replacement Spine | |
2023-UHC-781 | Deep Brain Cortical Stimulation | 2/7/23 | 3/24/23 | Approved | Deep Brain Cortical Stimulation | |
2023-UHC-788 | Mechanical Stretching Devices | 2/7/23 | 3/24/23 | Approved | Mechanical Stretching Devices | |
2023-UHC-791 | Neurophysiologic Testing | 2/7/23 | 3/24/23 | Approved | Neurophysiologic Testing | |
2023-UHC-948 | Catheter Ablation for Atrial Fibrillation | 2/7/23 | 3/24/23 | Approved | Catheter Ablation for Atrial Fibrillation | |
2023-UHC-1120 | Percutaneous Patent Foramen Ovale (PFO) Closure | 2/7/23 | 3/24/23 | Approved | Percutaneous Patent Foramen Ovale (PFO) Closure | |
2023-UHC-1792 | Public Communication and Marketing | 2/7/23 | 3/24/23 | Approved | Public Communication and Marketing | |
2023-UHC-1794 | Document Oversight and Adherence | 2/7/23 | 3/24/23 | Approved | Document Oversight and Adherence | |
2023-UHC-1808 | Peer Clinical Review | 2/7/23 | 3/24/23 | Denied | Peer Clinical Review | |
2023-UHC-1809 | Performance Assessment and Incentives | 2/7/23 | 3/24/23 | Approved | Performance Assessment and Incentives | |
2023-UHC-1815 | Sacral Nerve Stimulation for Urinary and Fecal Indications | 2/7/23 | 3/24/23 | Approved | Sacral Nerve Stimulation for Urinary and Fecal Indications | |
2023-UHC-1816 | Oral and Enteral Nutrition | 2/7/23 | 3/24/23 | Approved | Oral and Enteral Nutrition | |
2023-UHC-1817 | Proton Beam Radiation Therapy | 2/7/23 | 3/24/23 | Approved | Proton Beam Radiation Therapy | |
2023-LHCC-608 | Appeal of UM Decision | 1/27/23 | 3/13/23 | Complete | Appeal of UM Decision | |
2023-LHCC-931 | Appeals Process | 1/27/23 | 3/13/23 | Approved | Appeals Process | |
2023-UHC-1063 | Temporomandibular Joint Disorder | 1/27/23 | 3/13/23 | Approved | Temporomandibular Joint Disorder | |
2022-LHCC-1710 | Maternal Child Health Program Description | 1/27/23 | 3/13/23 | Approved | Maternal Child Health Program Description | |
2023-HBL-359 | Justice Involved Case Management | 1/25/23 | 3/11/23 | Approved | Justice Involved Case Management | |
2023-HBL-1241 | Advanced Imaging of the Head and Neck | 1/25/23 | 3/11/23 | Approved | Advanced Imaging of the Head and Neck | |
2023-HBL-1288 | Advanced Imaging of the Abdomen and Pelvis | 1/25/23 | 3/11/23 | Approved | Advanced Imaging of the Abdomen and Pelvis | |
2023-HBL-1718 | Coordinated Systems of Care (CSoC) | 1/25/23 | 3/11/23 | Approved | Coordinated Systems of Care (CSoC) | |
2022-ACLA-1734 | PCP Auto Assignment | 1/25/23 | 3/11/23 | Approved | PCP Auto Assignment | |
2022-HBL-1738 | LA UM Arow notification 20 visit | 1/25/23 | 3/11/23 | Approved | LA UM Arow notification 20 visit | |
2023-UHC-1799 | Case Manager Orientation and Performance Management | 1/25/23 | 3/11/23 | Complete | Case Manager Orientation and Performance Management | |
2023-UHC-1802 | Long Term Emergency Room Stay | 1/25/23 | 3/11/23 | Complete | Long Term Emergency Room Stay | |
2023-HBL-1812 | Screening for Vitamin D Deficiency in Average Risk Individuals | 1/25/23 | 3/11/23 | Approved | Screening for Vitamin D Deficiency in Average Risk Individuals | |
2023-HBL-1813 | Claim Processing Error Resolution | 1/25/23 | 3/11/23 | Complete | Claim Processing Error Resolution | |
2023-HBL-796 | Surface Electromyography Devices for Seizure Monitoring | 1/18/23 | 3/4/23 | Approved | Surface Electromyography Devices for Seizure Monitoring | |
2023-HBL-1012 | Oncologic Imaging AIM Guidelines | 1/18/23 | 3/4/23 | Approved | Oncologic Imaging AIM Guidelines | |
2023-HBL-1088 | Scoliosis Surgery | 1/18/23 | 3/4/23 | Approved | Scoliosis Surgery | |
2023-HBL-1220 | Gender Affirming Surgery | 1/18/23 | 3/4/23 | Approved | Gender Affirming Surgery | |
2023-HBL-1235 | Treatments for Urinary Incontinence | 1/18/23 | 3/4/23 | Approved | Treatments for Urinary Incontinence | |
2023-HBL-1254 | Hematopoietic Stem Cell Transplantation for Select Leukemias and Myelodysplastic Syndrome | 1/18/23 | 3/4/23 | Approved | Hematopoietic Stem Cell Transplantation for Select Leukemias and Myelodysplastic Syndrome | |
2023-HBL-1263 | Breast Procedures; including Reconstructive Surgery, Implants and Other Breast Procedures | 1/18/23 | 3/4/23 | Approved | Breast Procedures; including Reconstructive Surgery, Implants and Other Breast Procedures | |
2023-LHCC-1410 | Neurofeedback for Behavioral Health Disorders | 1/18/23 | 3/4/23 | Approved | Neurofeedback for Behavioral Health Disorders | |
2023-HBL-1444 | Gene Therapy for Beta Thalassemia | 1/18/23 | 3/4/23 | Approved | Gene Therapy for Beta Thalassemia | |
2023-HBL-1465 | Gene Therapy for Cerebral Adrenoleukodystrophy | 1/18/23 | 3/4/23 | Approved | Gene Therapy for Cerebral Adrenoleukodystrophy | |
2023-UHC-1466 | Provider Administered Drugs Site of Care | 1/18/23 | 3/4/23 | Approved | Provider Administered Drugs Site of Care | |
2023-LHCC-1521 | Permanent Supportive Housing | 1/18/23 | 3/4/23 | Approved | Permanent Supportive Housing | |
2023-UHC-1759 | Permanent Support Housing | 1/18/23 | 3/4/23 | Approved | Permanent Support Housing | |
2023-HBL-1781 | MRI of the Breast | 1/18/23 | 3/4/23 | Approved | MRI of the Breast | |
2023-HBL-1782 | Small Bowel, Small Bowel/Liver and Multivisceral Transplantation | 1/18/23 | 3/4/23 | Approved | Small Bowel, Small Bowel/Liver and Multivisceral Transplantation | |
2023-HBL-1783 | Mechanical Embolectomy for Treatment of Stroke | 1/18/23 | 3/4/23 | Approved | Mechanical Embolectomy for Treatment of Stroke | |
2023-HBL-1784 | Navigational Bronchoscopy | 1/18/23 | 3/4/23 | Approved | Navigational Bronchoscopy | |
2023-UHC-1785 | Plagiocephaly and Craniosynostosis Treatment | 1/18/23 | 3/4/23 | Approved | Plagiocephaly and Craniosynostosis Treatment | |
2023-HBL-1786 | Ingestible Devices for the Treatment of Constipation | 1/18/23 | 3/4/23 | Approved | Ingestible Devices for the Treatment of Constipation | |
2023-HBL-1787 | Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias | 1/18/23 | 3/4/23 | Approved | Hematopoietic Stem Cell Transplantation for Genetic Diseases and Aplastic Anemias | |
2023-HBL-1788 | Power Wheeled Mobility Devices | 1/18/23 | 3/4/23 | Approved | Power Wheeled Mobility Devices | |
2023-UHC-205 | Computed Tomographic Colonography | 1/18/23 | 3/4/23 | Approved | Computed Tomographic Colonography | |
2023-UHC-248 | Vertebral Tethering for Scoliosis | 1/18/23 | 3/4/23 | Approved | Vertebral Tethering for Scoliosis | |
2023-LHCC-730 | Heart MRI | 1/18/23 | 3/4/23 | Approved | Heart MRI | |
2023-LHCC-735 | Low Dose CT for Lung Cancer Screening | 1/18/23 | 3/4/23 | Approved | Low Dose CT for Lung Cancer Screening | |
2023-LHCC-739 | Lower Extremity MRI (foot, ankle, knee, leg, or hip MRI) | 1/18/23 | 3/4/23 | Approved | Lower Extremity MRI (foot, ankle, knee, leg, or hip MRI) | |
2023-LHCC-1429 | Heart PET with CT Attenuation | 1/13/23 | 2/27/23 | Approved | Heart PET with CT Attenuation | |
2023-LHCC-1756 | Facet Joint Denervation | 1/13/23 | 2/27/23 | Approved | Facet Joint Denervation | |
2023-HBL-1758 | Surgical Treatment of Hyperhidrosis | 1/13/23 | 2/27/23 | Approved | Surgical Treatment of Hyperhidrosis | |
2023-UHC-1760 | Radiation Therapy | 1/13/23 | 2/27/23 | Approved | Radiation Therapy | |
2023-UHC-1762 | Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery | 1/13/23 | 2/27/23 | Approved | Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery | |
2023-HBL-1763 | Medical Policy Formation | 1/13/23 | 2/27/23 | Approved | Medical Policy Formation | |
2023-LHCC-1764 | Single Photon Emission Computed Tomography SPECT | 1/13/23 | 2/27/23 | Approved | Single Photon Emission Computed Tomography SPECT | |
2023-HBL-1766 | Inpatient Interfaclity Transfers | 1/13/23 | 2/27/23 | Approved | Inpatient Interfaclity Transfers | |
2023-HBL-1767 | Skin Nerve Fiber Density Testing | 1/13/23 | 2/27/23 | Approved | Skin Nerve Fiber Density Testing | |
2023-HBL-1768 | Outpatient Urine Culture | 1/13/23 | 2/27/23 | Approved | Outpatient Urine Culture | |
2023-LHCC-1777 | Disclosure of Medical Necessity Criteria | 1/13/23 | 2/27/23 | Approved | Disclosure of Medical Necessity Criteria | |
2023-HBL-1778 | Outpatient Glycated Hemoglobin and Protein Testing | 1/13/23 | 2/27/23 | Approved | Outpatient Glycated Hemoglobin and Protein Testing | |
2023-HBL-1779 | Blepharoplasty, Blepharoptosis Repair and Brow Lift | 1/13/23 | 2/27/23 | Approved | Blepharoplasty, Blepharoptosis Repair and Brow Lift | |
2023-HBL-1780 | Foot Care Services | 1/13/23 | 2/27/23 | Approved | Foot Care Services | |
2022-LDH-17 | MCO Manual > Part 4: Services > In Lieu of Services > Behavioral Health Services (Proposed effective date = 1/1/2023) | 1/13/23 | 2/27/23 | Completed | Integrated Behavioral Health Homes | |
2023-LHCC-766 | Upper Extremity MRA/MRV | 1/13/23 | 2/27/23 | Approved | Upper Extremity MRA/MRV | |
2023-LHCC-767 | Upper Extremity MRI (Hand, Wrist, Elbow, Long bone, or Shoulder MRI) | 1/13/23 | 2/27/23 | Approved | Upper Extremity MRI (Hand, Wrist, Elbow, Long bone, or Shoulder MRI) | |
2023-LHCC-769 | Cardiac Resynchronization Therapy (CRT) | 1/13/23 | 2/27/23 | Approved | Cardiac Resynchronization Therapy (CRT) | |
2023-LHCC-770 | Fractional Flow Reserve CT | 1/13/23 | 2/27/23 | Approved | Fractional Flow Reserve CT | |
2023-LHCC-771 | Heart Catheterization | 1/13/23 | 2/27/23 | Approved | Heart Catheterization | |
2023-LHCC-775 | Stress Echocardiography | 1/13/23 | 2/27/23 | Approved | Stress Echocardiography | |
2023-LHCC-778 | Transthoracic (TTE) Echo | 1/13/23 | 2/27/23 | Approved | Transthoracic (TTE) Echo | |
2023-HBL-819 | HBL Provider Manual | 1/13/23 | 2/27/23 | Complete | HBL Provider Manual | |
2023-LHCC-994 | Ambulatory Insulin Pump | 1/13/23 | 2/27/23 | Approved | Ambulatory Insulin Pump | |
2023-HBL-1010 | Imaging of the Brain AIM Guidelines | 1/13/23 | 2/27/23 | Approved | Imaging of the Brain AIM Guidelines | |
2023-HBL-1014 | Imaging of the Chest AIM Guidelines | 1/13/23 | 2/27/23 | Approved | Imaging of the Chest AIM Guidelines | |
2023-HBL-1023 | Genetic Testing for Inherited Diseases | 1/13/23 | 2/27/23 | Approved | Genetic Testing for Inherited Diseases | |
2023-HBL-1038 | Enhanced External Counter pulsation in the Outpatient Setting | 1/13/23 | 2/27/23 | Approved | Enhanced External Counter pulsation in the Outpatient Setting | |
2023-LHCC-1168 | Allergy Testing & Therapy | 1/13/23 | 2/27/23 | Approved | Allergy Testing & Therapy | |
2023-HBL-1243 | Musculoskeletal Program- Interventional Pain Management | 1/13/23 | 2/27/23 | Approved | Musculoskeletal Program- Interventional Pain Management | |
2023-HBL-1258 | Iontophoresis | 1/13/23 | 2/27/23 | Approved | Iontophoresis | |
2023-LHCC-1267 | Cosmetic and Reconstructive Procedures | 1/13/23 | 2/27/23 | Approved | Cosmetic and Reconstructive Procedures | |
2023-LHCC-1273 | Orthognathic Surgery | 1/13/23 | 2/27/23 | Approved | Orthognathic Surgery | |
2023-LHCC-1277 | Panniculectomy | 1/13/23 | 2/27/23 | Approved | Panniculectomy |
Medicaid Managed Care Policies & Procedures Archive (2023) - Continued page 3
"Policy or procedure" shall mean a requirement governing the administration of managed care organizations specific to billing guidelines, medical management and utilization review guidelines, case management guidelines, claims processing guidelines and edits, grievance and appeals procedures and process, other guidelines or manuals containing pertinent information related to operations and pre-processing claims, and core benefits and services.
Below are items previously posted for public comment: